Literature DB >> 17279083

Neurological manifestations in Fabry's disease.

Anette T Møller1, Troels S Jensen.   

Abstract

Fabry's disease is an X-linked lysosomal storage disorder caused by a defect in the gene that encodes the lysosomal enzyme alpha-galactosidase A. Symptoms arise because of accumulation of globotriaosylceramide in multiple organs, resulting in severely reduced quality of life and premature death. Neurological symptoms, such as burning sensations (occasionally accompanied by acroparesthesia) and stroke, are among the first to appear, and occur in both male and female patients. A delay in establishing the diagnosis of Fabry's disease can cause unnecessary problems, especially now that enzyme replacement treatment is available to prevent irreversible organ damage. Females with Fabry's disease who present with pain have often been ignored and misdiagnosed because of the disorder's X-linked inheritance. This Review will stress the importance of recognizing neurological symptoms for the diagnosis of Fabry's disease. The possible pathophysiological background will also be discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17279083     DOI: 10.1038/ncpneuro0407

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  19 in total

1.  Fabry Disease Diagnosis in a Young Stroke Patient: A Case Report.

Authors:  Aslı Aksoy Gündoğdu; Dilcan Kotan; Murat Alemdar; Zeynep Özözen Ayas
Journal:  Noro Psikiyatr Ars       Date:  2018-07-17       Impact factor: 1.339

2.  Awareness of Fabry disease among rheumatologists--current status and perspectives.

Authors:  Rolando Cimaz; Severine Guillaume; Max J Hilz; Gerd Horneff; Bernhard Manger; J Carter Thorne; Anette Torvin Møller; Nico M Wulffraat; Johannes Roth
Journal:  Clin Rheumatol       Date:  2011-04       Impact factor: 2.980

3.  Electroneuromyographic Features in Fabry Disease: A Retrospective Review.

Authors:  Çetin Kürşad Akpinar; Hande Türker; Oytun Bayrak; Nilgün Cengiz
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

4.  Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.

Authors:  G Messalli; M Imbriaco; G Avitabile; R Russo; D Iodice; L Spinelli; S Dellegrottaglie; F Cademartiri; M Salvatore; A Pisani
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

5.  FabryScan: a screening tool for early detection of Fabry disease.

Authors:  Kathrin Arning; Dennis Naleschinski; Rainer Maag; Marieke Biegstraaten; Peter Kropp; Jürgen Lorenzen; Carla E M Hollak; Ivo N van Schaik; Pontus Harten; Rainald A Zeuner; Andreas Binder; Ralf Baron
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

6.  Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.

Authors:  Alessandro Salviati; Alessandro P Burlina; Walter Borsini
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

Review 7.  Enzyme replacement therapy for Fabry disease: a systematic review of available evidence.

Authors:  Roland M Schaefer; Anna Tylki-Szymańska; Max J Hilz
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

Review 8.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

9.  The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain.

Authors:  L Choi; J Vernon; O Kopach; M S Minett; K Mills; P T Clayton; T Meert; J N Wood
Journal:  Neurosci Lett       Date:  2015-02-16       Impact factor: 3.046

10.  A Case of Cerebral Aneurysmal Subarachnoid Hemorrhage in Fabry's Disease.

Authors:  Youn Hyuk Chang; Sung-Kyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.